Screener
TG Therapeutics TGTX License — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product revenue, net | $235,794 | $138,843 | $437,102 | $258,498 |
| License, milestone, royalty and other revenue | 4,541 | 2,305 | 8,151 | 3,506 |
| Total revenue | $240,335 | $141,148 | $445,253 | $262,004 |
| Costs and expenses: | ||||
| Cost of revenue | 41,194 | 18,938 | 74,704 | 34,479 |
| Research and development: | ||||
| Stock-based compensation | 8,070 | 4,318 | 12,945 | 7,649 |
Document
FAQ
- What is TG Therapeutics's license — revenue?
- TG Therapeutics (TGTX) reported license — revenue of $4.54M in Q2 2026.
- How has TG Therapeutics's license — revenue changed year-over-year?
- TG Therapeutics's license — revenue increased by 97.0% year-over-year, from $2.31M to $4.54M.
- What is the long-term trend for TG Therapeutics's license — revenue?
- Over 4 years (2021 to 2025), TG Therapeutics's license — revenue has grown at a 180.1% compound annual growth rate (CAGR), from $152K to $9.36M.
- What does license — revenue mean?
- This metric represents the revenue recognized from licensing intellectual property, technology, or pharmaceutical assets to third-party partners. It reflects the financial inflows generated through contractual arrangements where the company grants rights to its proprietary assets in exchange for upfront payments, milestones, or royalties. This stream is distinct from direct product sales and highlights the company's ability to monetize its research and development pipeline through strategic partnerships.
Ask your AI about TG Therapeutics's license — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude